403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Tubeless Insulin Pump Market Size USD 13.65 Billion By 2034
| Report Coverage | Details |
| Growth Rate (2025–2034) | CAGR of 18.74% |
| Market Size in 2025 | USD 2.92 Billion |
| Market Size in 2025 | USD 3.48 Billion |
| Market Size by 2034 | USD 13.65 Billion |
| Base Year | 2024 |
| Forecast Period | 2025–2034 |
| Segments Covered | Type, Component, End-users |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Market Definition | Focuses on wearable, tube-free insulin delivery systems designed for continuous, automated glucose management without external tubing. |
| Core Growth Drivers | Rising diabetes prevalence, preference for discreet insulin delivery, increased adoption of wearable health tech, improved reimbursement pathways. |
| Key Restraints | High device cost, limited awareness in low-income regions, dependence on battery and sensor accuracy, device availability inconsistencies. |
| Opportunities | AI-integrated glucose algorithms, smartphone-connected pump ecosystems, expansion into pediatric diabetes care, next-gen skin-friendly patch materials. |
| Technology Trends | Closed-loop insulin automation, Bluetooth-enabled pod monitoring, long-wear adhesive patches, integration with CGM systems, miniaturized disposable pods. |
| Type Insights | Insulin patch pumps dominate due to ease-of-use, compact design, and elimination of tubing-related complications. |
| Component Insights | Pod/patch segment leads because of rising adoption of disposable, wearable insulin delivery pods with integrated reservoirs. |
| End-User Insights | Hospitals hold the largest share owing to first-line device training, diabetes management programs, and rapid adoption of advanced insulin therapies. |
| Patient Demographics | Strong uptake among Type 1 diabetes patients and younger demographics seeking mobility and lifestyle flexibility. |
| Competitive Landscape | Market led by innovators in patch-pump automation, expanding sensor integration, and user-centric device miniaturization. |
| Future Outlook | Movement toward fully automated, closed-loop, tubeless insulin ecosystems with multi-day pods and real-time mobile analytics. |
Immediate Delivery Available | Buy This Premium Research Report@
Tubeless Insulin Pump Market Regional Insights
North America Tubeless Insulin Pump Market
North America dominated the global market in 2024, with a share of 55%, due to e-commerce
North American manufacturing giants are focusing on advancements in technologies like smartphone-controlled pumps. The high prevalence of diabetes and well-established healthcare infrastructure fueling this growth. Additionally, the existence of key leading players like Tandem, Medtronic, and Inset are investing heavily in features like boosting accuracy, discreet deigns, and user-friendliness.
How Big is the U.S. Tubeless Insulin Pump Market Size?
According to Precedence Research, the U.S. tubeless insulin pump market size is valued at USD 1.12 billion in 2025, and it is anticipated to reach around USD 5.34 billion by 2034, growing at a double digit CAGR of 18.97% between 2025 and 2034.
High Number of Diabetics in the U.S. Fuels the Market Growth
The dominance of the United States in the North American tubeless insulin pump market is underpinned by several compelling interrelated factors that go beyond simply having a large diabetic population. The U.S. has one of the high insulin-dependent diabetes country across the globe.
The US healthcare and reimbursement environment strongly favors newer technologies: favorable insurance or government reimbursement, clear regulatory pathways (such as fast-track approvals for devices like tubeless pumps), and growing patient and clinician awareness all help accelerate uptake.
- According to the Association of Diabetes Care & Education Specialists, there are one million people with diabetes on insulin pump therapy worldwide and 350000 to 515000 in the United States. Source:
Asia Pacific Tubeless Insulin Pump Market
Asia Pacific is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034 because of the lifestyle changes in developing regions, increasing senior population, strategic collaboration, suitable insurance coverage, user-friendly interfaces, integration with CGM & AI, and improved quality of life in the region. More than 1000 patients use an insulin pump on a continuous basis in India.
The growing diabetes prevalence and rising demand for more user-friendly devices are fueling this market. Additionally, the focus on leveraging tubeless systems with CGMs and longer-lasting pump design developments is enabling advanced tubeless insulin pumps across Asian healthcare.
Rising Disposable Income: Fueling Healthcare Spending in China
China dominates the regional market, due to several key drivers. China captured the largest revenue share in the Asia-Pacific tubeless insulin pump market in 2024, driven by its large and growing diabetic population, rapid urbanization, rising disposable incomes and improved access to healthcare infrastructure.
The combination of a sizeable middle class willing to adopt advanced medical devices, stronger investment in diabetes care and remote-health/digital platforms. Another key driver is the rapid urbanization and economic growth in China, China has also made significant investments, including hospitals.
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at ...Tubeless Insulin Pump Market Segmentation Outlook:
Type Outlook
Which Type Segment Dominates the Tubeless Insulin Pump Market
The insulin patch pump segment dominated the market in 2024. Patch pumps increase patient satisfaction, reduce diabetes-related distress, improve quality of life, and are preferred by patients compared to conventional insulin pumps and multiple daily injection therapy (MDI). Like automated insulin delivery systems, the insulin patch needs no programming, no dependence on digital technology. Patch pump systems are increasingly used to be increasingly in control of T1DM and can be incorporated into the artificial pancreas systems of the future. Patch pumps are unobtrusive, lightweight, small, and free of tubing.
The traditional pump segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034. The traditional pump is generally larger, about the size of a grapefruit, and needs to be plugged into an electrical outlet to work. Traditional pumps include an insulin reservoir and a catheter. The catheter is inserted with a plastic needle just under the skin into fatty tissue. This is held in a place with a sticky bandage.
Component Outlook
Which Component Dominates the Tubeless Insulin Pump Market?
The pod or patch segment accounted for a considerable share of the market in 2024. The pod is a microprocessor-controlled device worn directly on the body. It delivers insulin based on the user's custom-programmed basal rates and bolus doses for up to 3 days according to the patient's individual insulin needs. Patch pumps are smaller, more discrete, easier to use, and may be cheaper than conventional insulin pumps.
The accessories segment is projected to experience the highest growth rate in the market between 2025 and 2034. An insulin pump is a wearable medical device that supplies a continuous flow of insulin under the skin. It is an alternative to insulin injections. The pump contains the battery
End-users Outlook
What Made the Hospital Lead the Tubeless Insulin Pump Market?
The hospital segment led the market. It is a conducive place for people who need treatment for their illness. It plays an important role in the community. In most cases, the hospital cash benefit is only applicable if the insured has been hospitalized for a minimum of 48 hours. Hospital facilities like ambulance services, dietary, CSSD, blood bank services, emergency operation theatres, labor room, emergency laboratory services, plaster room, X-rays, MRI, CT, Ultrasound, and ECG.
The e-commerce segment is set to experience the fastest rate of market growth from 2025 to 2034. E-commerce (electronic commerce) allows the exchange and movement of goods. E-commerce refers to commercial activities, including the electronic buying or selling of products and services, which are conducted on online platforms or over the internet.
The kind of commerce also includes aspects like customer service, managing inventory, digital marketing, and online payments. The e-commerce benefits include improved clarity, ease of access, advanced catalogue filtering, improved patient privacy and data security, time efficiency, supply chain integrity, scalability & flexibility, prescription management system, and more.
✚ Related Topics You May Find Useful:
➡️ Implantable Insulin Pumps Market➡️ Digital Diabetes Management Market
➡️ Infusion Pump Market
➡️ Continuous Glucose Monitoring Device Market
➡️ Insulin Delivery Devices Market
➡️ Diabetes Devices Market
➡️ Point-of-Care Glucose Testing Market
➡️ Insulin Market
➡️ Wearable Injectors Market
Tubeless Insulin Pump Market Top Companies
- Valeritas Holdings: Offered the V-Go Wearable Insulin Delivery device, a simple, disposable, and non-electronic patch pump for basal-bolus insulin therapy, designed primarily for people with Type 2 diabetes.
CeQur: Offers the Simplicity patch, a wearable, disposable device for delivering mealtime and correction boluses of rapid-acting insulin, which is not a full-featured pump but an alternative to injections.
Debiotech: Developed the JewelPUMP, a two-part reusable and disposable patch pump based on MEMS technology that was designed for precision insulin delivery.
Medtrum Technologies: Developed the A6 TouchCare System, which includes the P6 EasyPatch, a tubeless, disposable insulin patch pump that integrates with a CGM and a mobile app.
Roche Holdings: Developed the Accu-Chek Solo micropump system, a two-part patch pump that is wirelessly controlled and can be detached and re-attached without wasting insulin.
Cellnova: Developed a compact, tubeless, mobile, and connected insulin patch pump system with a touchscreen controller, which also featured an activity monitor and integrated blood glucose meter.
JingasuDelfu Co., Ltd.: This company, identified as Jiangsu Delfu medical device Co., Ltd., develops and manufactures various medical devices, and provides an adjustable, smart diabetes insulin pump.
Animas Corporation: Animas was a manufacturer of traditional, tubed insulin pumps (like the Animas Vibe) and was a subsidiary of Johnson & Johnson, but it did not offer a tubeless pump before being shut down.
Johnson & Johnson: While their former subsidiary, Animas, made tubed pumps, Johnson & Johnson does not market a proprietary tubeless insulin pump and their previous diabetes division has been largely divested.
Spring Health Solutions: A participant in the tubeless pump market, with some involvement in developing such systems. Research has not identified a widely commercialized product from the company.
Other Key Players:
- Sooil Development Insulet Corporation Tandem Diabetic Care, Inc. Hoffmann-La Roche Ltd Medtronic plc TERUMO Mannkind Corporation
Recent Developments
- In September 2025, the creation of Omnipod Mango, a bright and joyful tropical orange-yellow, was announced by Insulet Corporation, the global leader in tubeless insulin pump technology, with its Omnipod brand of products in collaboration with Pantone, the global authority on color and provider of professional color standards for the design industries. Omnipod Mango is separately selected to celebrate the radiance of the diabetes community and symbolizes Insulet's passion and commitment to enhancing the lives of people with diabetes and making it a smaller part of life. Source:
In April 2025, Omnipod® 5 Automated Insulin Delivery System in Canada, a revolutionary new technology for people living with type 1 diabetes ages 2 years and above, was launched by Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod brand of products. Omnipod 5 is the first waterproof, tubeless, Automated Insulin Delivery (AID) System approved for use in Canada for people with type 1 diabetes ages 2 years and over. Source:
Segments Covered in the Report
By Type
- Insulin Patch Pump Traditional Pump
By Component
- Pod or Patch Remote Accessories
By End-users
- Hospitals Pharmacies E-commerce
By Region
- North America Europe Asia-Pacific Latin America Middle East and Africa
Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as North America, Europe, or Asia Pacific.
Immediate Delivery Available | Buy This Premium Research Report@You can place an order or ask any questions, please feel free to contact at ... | +1 804 441 9344
Stay Ahead with Precedence Research Subscriptions
Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve.
Browse Our Subscription Plans@About Us
Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Web:Our Trusted Data Partners:
Towards Healthcare | Towards Packaging | Towards Automotive | Towards Chem and Materials | Towards FnB | Towards Consumer Goods | Statifacts | Towards EV Solutions | Towards Dental | Nova One Advisor Market Stats Insight | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant Specialty Chemicals AnalyticsGet Recent News:
/newsFor the Latest Update Follow Us:
LinkedIn | Medium | Facebook | Twitter✚ Explore More Market Intelligence from Precedence Research:
➡️ Biopharmaceuticals Growth➡️ Digital Therapeutics
➡️ Life Sciences Growth
➡️ Viral Vector Gene Therapy Manufacturing
➡️ Wellness Transformation
➡️ Generative AI in Healthcare
➡️ Quantum Future
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment